These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27956635)

  • 1. Low-stringency selection of TEM1 for BLIP shows interface plasticity and selection for faster binders.
    Cohen-Khait R; Schreiber G
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):14982-14987. PubMed ID: 27956635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into Structure-Function Relationships of β-Lactamase and BLIPs Interface Plasticity using Protein-Protein Interactions.
    Yadav TC; Agarwal V; Srivastava AK; Raghuwanshi N; Varadwaj P; Prasad R; Pruthi V
    Curr Pharm Des; 2019; 25(31):3378-3389. PubMed ID: 31544712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting for Fast Protein-Protein Association As Demonstrated on a Random TEM1 Yeast Library Binding BLIP.
    Cohen-Khait R; Schreiber G
    Biochemistry; 2018 Aug; 57(31):4644-4650. PubMed ID: 29671590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interdomain flexibility and interfacial integrity of β-lactamase inhibitory protein (BLIP) modulate its binding to class A β-lactamases.
    Huang L; So PK; Chen YW; Leung YC; Yao ZP
    J Biol Chem; 2021 Aug; 297(2):100980. PubMed ID: 34302811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Sequencing of a Systematic Peptide Library Reveals Conformationally-Constrained Protein Interface Peptides that Disrupt a Protein-Protein Interaction.
    Boragine DM; Huang W; Su LH; Palzkill T
    Chembiochem; 2022 Feb; 23(3):e202100504. PubMed ID: 34821011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and computational characterization of the SHV-1 beta-lactamase-beta-lactamase inhibitor protein interface.
    Reynolds KA; Thomson JM; Corbett KD; Bethel CR; Berger JM; Kirsch JF; Bonomo RA; Handel TM
    J Biol Chem; 2006 Sep; 281(36):26745-53. PubMed ID: 16809340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and biochemical characterization of the interaction between KPC-2 beta-lactamase and beta-lactamase inhibitor protein.
    Hanes MS; Jude KM; Berger JM; Bonomo RA; Handel TM
    Biochemistry; 2009 Oct; 48(39):9185-93. PubMed ID: 19731932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.
    Brown NG; Palzkill T
    Protein Eng Des Sel; 2010 Jun; 23(6):469-78. PubMed ID: 20308189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of β-lactamase residues in a common interface for binding the structurally unrelated inhibitory proteins BLIP and BLIP-II.
    Fryszczyn BG; Adamski CJ; Brown NG; Rice K; Huang W; Palzkill T
    Protein Sci; 2014 Sep; 23(9):1235-46. PubMed ID: 24947275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A β-Lactamases.
    Adamski CJ; Palzkill T
    Biochemistry; 2017 Feb; 56(8):1075-1084. PubMed ID: 28182405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into positive and negative requirements for protein-protein interactions by crystallographic analysis of the beta-lactamase inhibitory proteins BLIP, BLIP-I, and BLP.
    Gretes M; Lim DC; de Castro L; Jensen SE; Kang SG; Lee KJ; Strynadka NC
    J Mol Biol; 2009 Jun; 389(2):289-305. PubMed ID: 19332077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the β-lactamase inhibitor protein-II (BLIP-II) interface residues essential for binding affinity and specificity for class A β-lactamases.
    Brown NG; Chow DC; Ruprecht KE; Palzkill T
    J Biol Chem; 2013 Jun; 288(24):17156-66. PubMed ID: 23625930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping Protein-Protein Interaction Interface Peptides with Jun-Fos Assisted Phage Display and Deep Sequencing.
    Huang W; Soeung V; Boragine DM; Palzkill T
    ACS Synth Biol; 2020 Jul; 9(7):1882-1896. PubMed ID: 32502338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding hot spots in the TEM1-BLIP interface in light of its modular architecture.
    Reichmann D; Cohen M; Abramovich R; Dym O; Lim D; Strynadka NC; Schreiber G
    J Mol Biol; 2007 Jan; 365(3):663-79. PubMed ID: 17070843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of faster associating and tighter binding protein complexes.
    Selzer T; Albeck S; Schreiber G
    Nat Struct Biol; 2000 Jul; 7(7):537-41. PubMed ID: 10876236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic substitutions at BLIP position 50 result in changes in binding specificity for class A β-lactamases.
    Adamski CJ; Palzkill T
    BMC Biochem; 2017 Mar; 18(1):2. PubMed ID: 28264645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action-at-a-distance interactions enhance protein binding affinity.
    Joughin BA; Green DF; Tidor B
    Protein Sci; 2005 May; 14(5):1363-9. PubMed ID: 15802650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity and cooperativity at β-lactamase position 104 in TEM-1/BLIP and SHV-1/BLIP interactions.
    Hanes MS; Reynolds KA; McNamara C; Ghosh P; Bonomo RA; Kirsch JF; Handel TM
    Proteins; 2011 Apr; 79(4):1267-76. PubMed ID: 21294157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical characterization of the interaction of the beta-lactamase TEM-1 with its protein inhibitor BLIP.
    Albeck S; Schreiber G
    Biochemistry; 1999 Jan; 38(1):11-21. PubMed ID: 9890878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of residues in beta-lactamase critical for binding beta-lactamase inhibitory protein.
    Rudgers GW; Palzkill T
    J Biol Chem; 1999 Mar; 274(11):6963-71. PubMed ID: 10066750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.